MarketPR
Pomerantz LLP, the New York-based plaintiff securities law firm, has announced the filing of a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS), the genomic diagnostics company.
The firm is alerting investors who recorded losses on WGS holdings and flagging approaching legal deadlines for participation in the case.
The Lawsuit Pomerantz LLP, which operates under the Pomerantz Law Firm name in investor-facing communications, confirmed the class action was filed against GeneDx Holdings Corp., traded on the Nasdaq exchange under the ticker WGS.
The announcement, issued from New York on July 2, 2026, did not disclose the specific allegations underpinning the complaint, the dollar value of damages sought, or the precise deadline dates in the source material available at publication.
Keep reading